BarbriSFCourseDetails
  • videocam On-Demand
  • signal_cellular_alt Intermediate
  • card_travel Health
  • schedule 90 minutes

New CMS Medicare Advantage Final Rule: Beneficiary Data, Agent Compensation, Behavioral Healthcare Access, and More

$297.00

This course is $0 with these passes:

CLE
ALL
  1. keyboard_arrow_leftBack
BarbriPdBannerMessage

Description

CMS recently released the CY 2025 Medicare Advantage and Part D final rule, effective Oct. 1, 2024, that makes significant changes to certain CMS policies including to promote competition, protect beneficiaries' data from being used inappropriately for marketing, increase access to behavioral health services, promote equity in coverage, and improve supplemental benefits.

One of the most notable changes in the final rule is related to agent/broker compensation to stop what CMS says is anticompetitive steering of enrollees toward some Medicare Advantage (MA) and Part D plans over others based on the agent/broker's financial interests rather than the enrollee's healthcare needs. The final rule caps agent/broker non-salary compensation, eliminates separate payments for administrative services, and intends for compensation to encompass all administrative fees and commissions paid to independent agents/brokers. The final rule also prohibits contractual terms that create incentives to enroll beneficiaries in plans other than in the best interests of the beneficiary and that provide bonuses for hitting volume-based sales targets for plan sales.

Other significant updates include requiring express written consent from beneficiaries before third-party marketing organizations (TPMOs) may share personal beneficiary data with other TPMOs for marketing or enrollment purposes; improving access to behavioral healthcare services by finalizing important updates to network adequacy standards; and requiring MA plans to issue mid-year notices to enrollees that include a list of supplemental benefits to which they are entitled but have not yet accessed.

Listen as our expert panel guides practitioners through the notable changes in the CMS CY 2025 Medicare Advantage and Part D final rule and offers best practices for compliance.

Presented By

Christina Bergeron
Partner
Ropes & Gray

Ms. Bergeron provides strategic business and regulatory counsel to prominent health care and private equity clients. She regularly advises on complex transactions across a wide range of health care industry sectors. Ms. Bergeron has been advising clients on a range of issues associated with the pandemic, including navigating financial relief provisions for health care providers under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act).

expand_circle_down Expand to View Full Bio expand_circle_up Collapse Bio
Helaine I. Fingold
Member
Epstein Becker & Green PC

Ms. Fingold’s practice focuses largely on the regulation of Medicare managed care (including Medicare Advantage, Part D, dual eligibles, PACE, demonstrations), Medicaid managed care, commercial managed care products (including surprise billing), and behavioral health (including mental health parity). Her clients range from small start-ups to large corporate entities with multiple subsidiaries. They include Medicare Advantage, PACE, Medicaid, and other managed care plans; provider entities; vendors to providers and managed care companies (including administrative support entities, providers of software and online services, agents/brokers/field marketing organizations, and advertising/marketing entities). Before building her private practice, Ms. Fingold gained 20 years of experience in the federal government: 13 years at CMS, working on Medicaid, Medicare Advantage/Part D, and ACA implementation, and seven years at MedPAC.

expand_circle_down Expand to View Full Bio expand_circle_up Collapse Bio
Credit Information

  • This 90-minute webinar is eligible in most states for 1.5 CLE credits.


  • Live Online


    On Demand

Date + Time

  • event

    Thursday, July 11, 2024

  • schedule

    1:00 p.m. ET./10:00 a.m. PT

  1. Introduction
  2. Medicare Advantage Part C and Part D prescription drug plan marketing
    1. Agent and broker compensation
    2. Distribution of personal beneficiary data by TPMOs
  3. Improving access to behavioral healthcare providers
  4. Supplemental benefits
    1. Mid-year enrollee notification of available supplemental benefits
    2. New standards for special supplemental benefits for the chronically ill
  5. Annual health equity analysis of utilization management policies and procedures
  6. Other changes
  7. Practitioner takeaways

The panel will review these and other important considerations:

  • How does the final rule encourage competition?
  • What impact will the final rule's requirements related to administrative fees and capped compensation have on agents/brokers?
  • What is the status of the recent lawsuits filed to challenge these regulatory changes?
  • In what ways does the final rule promote equity and access to healthcare?
  • How will the final rule's requirements improve supplemental benefits available to enrollees?
  • What are best practices for navigating the final rule's requirements and ensuring compliance?